Aurobindo Pharma announces ₹800 Cr buyback, check details hereAurobindo Pharma announces ₹800 Cr buyback, check details here

Introduction

Leading pharmaceutical firm announced a share buyback of 54.23 lakh equity shares at ₹1,475 each, totaling ₹800 crore. Record date for participation is April 17, 2026.

Also Read: Latent View Analytics backs Healtheon AI with $3M strategic investment, stock moves up 16%

Share price movement of Aurobindo Pharma

On April 06, 2026, Aurobindo Pharma Ltd opened at ₹1,344.25, up 0.63% from its previous close of ₹1,335.95. The stock reached a high of ₹1,356.00 (1.52%) and a low of ₹1,318.25. By 11:30 AM, it traded at ₹1,332.80, a 0.24% decrease, with a market cap of ₹77,409.24 crore.

Aurobindo Pharma Approves Share Buyback

Shares of Aurobindo Pharma gained attention on April 6, 2026. The company announced a buyback program of up to 54,23,728 equity shares. Each share has a face value of ₹1.

The buyback represents 0.93% of the total paid-up equity shares. The company will pay ₹1,475 per share in cash. The total buyback amount is capped at ₹800 crore.

Record Date

Aurobindo Pharma has set April 17, 2026, as the record date. Shareholders eligible on this date can participate in the buyback. The record date follows regulatory guidelines.

The buyback was approved by the company’s board. It follows regulations under the Listing Regulations and Buyback Regulations. Payment will be made in cash to participating shareholders.

Buyback details

Particulars	Description
Number of securities proposed for buyback	54,23,728
Number of securities proposed for buyback as a percentage of existing paid-up capital	0.93%
Buyback price	INR 1,475/- (Indian Rupee one thousand four hundred and seventy-five only) per equity share
Actual securities in number and percentage of existing paid-up capital bought back	Not applicable
Pre and post buyback shareholding pattern	Pre buyback shareholding pattern of the Company is provided in Annexure A and the post buyback shareholding shall be ascertained subsequently.

Stock performance of Aurobindo Pharma for period of 1 week, 6 months, and 1 year

Aurobindo Pharma Ltd delivered a 1-week return of 2.25%, a 6-month return of 24.6%, and a 1-year return of 20.7%.

Also Read: Jubilant FoodWorks secures 15-year extension for Domino’s India rights

Shareholding pattern of Aurobindo Pharma

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	51.80%	51.80%	51.80%
FII	14.00%	14.20%	14.40%
DII	27.70%	27.60%	26.90%
Public	6.60%	6.40%	6.90%

About Aurobindo Pharma

Aurobindo Pharma Ltd (NSE: AUROPHARMA) is a leading pharmaceutical company, India’s 2nd-largest by revenue, top US generics firm, and ranks among top 10 in eight European countries.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs